Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Roivant Sciences (ROIV) EBT: 2021-2025

Historic EBT for Roivant Sciences (ROIV) over the last 5 years, with Mar 2025 value amounting to -$681.6 million.

  • Roivant Sciences' EBT rose 29.12% to -$159.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$887.2 million, marking a year-over-year decrease of 119.01%. This contributed to the annual value of -$681.6 million for FY2025, which is 114.92% down from last year.
  • Latest data reveals that Roivant Sciences reported EBT of -$681.6 million as of FY2025, which was down 114.92% from $4.6 billion recorded in FY2024.
  • Roivant Sciences' EBT's 5-year high stood at $4.6 billion during FY2024, with a 5-year trough of -$923.7 million in FY2022.
  • Its 3-year average for EBT is $1.0 billion, with a median of -$681.6 million in 2025.
  • Per our database at Business Quant, Roivant Sciences' EBT spiked by 616.15% in 2024 and then tumbled by 114.92% in 2025.
  • Roivant Sciences' EBT (Yearly) stood at -$898.5 million in 2021, then declined by 2.80% to -$923.7 million in 2022, then grew by 4.20% to -$885.0 million in 2023, then skyrocketed by 616.15% to $4.6 billion in 2024, then crashed by 114.92% to -$681.6 million in 2025.